Saturday 13 December 2014

Global Herpes Market 2014-2018

Global Herpes Market 2014-2018 is a new market research publication announced by Reportstack. Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, treatments can help reduce the pain and decrease healing period.
The analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.
Key Regions
• Americas 
• APAC
• EMEA 
Key Vendors
• Gilead Sciences 
• GSK 
• Merck 
• Novartis 
Other Prominent Vendors
• Agenus 
• AiCuris 
• aRigen Pharmaceuticals
• Astellas Pharma
• CytoGenix
• Epiphany Biosciences
• F. Hoffmann-La Roche
• Genocea Biosciences
• NanoBio
Market Driver
• Significant Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• Increasing Generic Competition
• For a full, detailed list, view our report
Market Trend
• Promising New Launches
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Companies Mentioned
Gilead Sciences , GSK , Merck , Novartis , Agenus , AiCuris , aRigen Pharmaceuticals, Astellas Pharma, CytoGenix, Epiphany Biosciences, F. Hoffmann-La Roche, Genocea Biosciences, NanoBioTo view the table of contents and know more details please visit Global Herpes Market 2014-2018

No comments:

Post a Comment